{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:24:56Z","timestamp":1787599496740,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772993"],"award-info":[{"award-number":["81772993"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2018J01151"],"award-info":[{"award-number":["2018J01151"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.biopha.2022.113076","type":"journal-article","created":{"date-parts":[[2022,5,10]],"date-time":"2022-05-10T06:54:33Z","timestamp":1652165673000},"page":"113076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["The anti-inflammatory effect of Pien Tze Huang in non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"151","author":[{"given":"Baohuan","family":"Lian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuquan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2022.113076_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10290","key":"10.1016\/j.biopha.2022.113076_bib2","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.biopha.2022.113076_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.biopha.2022.113076_bib4","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.tem.2018.08.003","article-title":"Role of innate immune signaling in non-alcoholic fatty liver disease","volume":"29","author":"Cai","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.biopha.2022.113076_bib5","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1053\/j.gastro.2016.01.025","article-title":"Inflammation in alcoholic and nonalcoholic fatty liver disease: friend or foe?","volume":"150","author":"Gao","year":"2016","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.biopha.2022.113076_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11154-016-9339-2","article-title":"The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH)","volume":"17","author":"Nati","year":"2016","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"1","key":"10.1016\/j.biopha.2022.113076_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular pathways of nonalcoholic fatty liver disease development and progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.biopha.2022.113076_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12944-017-0572-9","article-title":"A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease","volume":"16","author":"Chen","year":"2017","journal-title":"Lipids Health Dis."},{"issue":"2 Suppl 1","key":"10.1016\/j.biopha.2022.113076_bib9","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.113076_bib10","first-page":"57","article-title":"Therapy of nonalcoholic fatty liver disease: current status","volume":"60 Suppl 7","author":"Duvnjak","year":"2009","journal-title":"J. Physiol. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113076_bib11","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2022.113076_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111326","article-title":"New insight and potential therapy for NAFLD: CYP2E1 and flavonoids","volume":"137","author":"Wang","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.biopha.2022.113076_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.biopha.2022.113076_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","article-title":"IKK-beta links inflammation to obesity-induced insulin resistance","volume":"11","author":"Arkan","year":"2005","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.biopha.2022.113076_bib15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2022.113076_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/oby.2010.200","article-title":"FFA-induced adipocyte inflammation and insulin resistance: involvement of ER stress and IKKbeta pathways","volume":"19","author":"Jiao","year":"2011","journal-title":"Obesity"},{"issue":"11","key":"10.1016\/j.biopha.2022.113076_bib17","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","article-title":"NAFLD, NASH and liver cancer","volume":"10","author":"Michelotti","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.biopha.2022.113076_bib18","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.7150\/thno.42658","article-title":"PTPROt aggravates inflammation by enhancing NF-kappaB activation in liver macrophages during nonalcoholic steatohepatitis","volume":"10","author":"Jin","year":"2020","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.biopha.2022.113076_bib19","first-page":"1069","article-title":"Muscone exerts neuroprotection in an experimental model of stroke via inhibition of the fas pathway","volume":"7","author":"Wei","year":"2012","journal-title":"Nat. Prod. Commun."},{"issue":"8","key":"10.1016\/j.biopha.2022.113076_bib20","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1211\/jpp.58.8.0001","article-title":"Pharmacological activity of sanchi ginseng (Panax notoginseng)","volume":"58","author":"Ng","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113076_bib21","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1007\/s11999-009-1079-0","article-title":"Muscone protects vertebral end-plate degeneration by antiinflammatory property","volume":"468","author":"Liang","year":"2010","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"16","key":"10.1016\/j.biopha.2022.113076_bib22","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2174\/1389557516666160919164352","article-title":"A review of three commonly used herbs which enhance memory and new evidences which show their combination could improve memory in young animals","volume":"17","author":"Hong","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"issue":"23","key":"10.1016\/j.biopha.2022.113076_bib23","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.2174\/092986711796642535","article-title":"How would composite traditional Chinese medicine protect the brain--an example of the composite formula \u201cPien Tze Huang\u201d","volume":"18","author":"Zhang","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2022.113076_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/00207450802324770","article-title":"Pien Tze Huang, a composite Chinese traditional herbal extract, affects survival of neuroblastoma cells","volume":"119","author":"Lu","year":"2009","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.biopha.2022.113076_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1749-8546-5-35","article-title":"Protective effects and potential mechanisms of Pien Tze Huang on cerebral chronic ischemia and hypertensive stroke","volume":"5","author":"Zhang","year":"2010","journal-title":"Chin. Med."},{"issue":"5","key":"10.1016\/j.biopha.2022.113076_bib26","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.3892\/etm.2017.4174","article-title":"Pien Tze Huang Gan Bao ameliorates carbon tetrachloride-induced hepatic injury, oxidative stress and inflammation in rats","volume":"13","author":"Zhao","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2022.113076_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.111856","article-title":"Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-kappaB pathway and promoting HSC apoptosis","volume":"244","author":"Zheng","year":"2019","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113076_bib28","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3892\/or.2013.2609","article-title":"Pien Tze Huang inhibits tumor angiogenesis in a mouse model of colorectal cancer via suppression of multiple cellular pathways","volume":"30","author":"Shen","year":"2013","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2022.113076_bib29","first-page":"1113","article-title":"Pien Tze Huang ameliorates DSSinduced colonic inflammation in a mouse colitis model through inhibition of the IL6\/STAT3 pathway","volume":"18","author":"Li","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.biopha.2022.113076_bib30","first-page":"1569","article-title":"Pien Tze Huang inhibits tumor cell proliferation and promotes apoptosis via suppressing the STAT3 pathway in a colorectal cancer mouse model","volume":"40","author":"Zhuang","year":"2012","journal-title":"Int. J. Oncol."},{"issue":"6","key":"10.1016\/j.biopha.2022.113076_bib31","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.3892\/or.2012.2067","article-title":"Pien Tze Huang suppresses IL-6-inducible STAT3 activation in human colon carcinoma cells through induction of SOCS3","volume":"28","author":"Shen","year":"2012","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.biopha.2022.113076_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111814","article-title":"Pien-Tze-Huang, a Chinese patent formula, attenuates NLRP3 inflammasome-related neuroinflammation by enhancing autophagy via the AMPK\/mTOR\/ULK1 signaling pathway","volume":"141","author":"Huang","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.biopha.2022.113076_bib33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.4829","article-title":"Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances","volume":"241","author":"Lau","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.biopha.2022.113076_bib34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.phrs.2019.03.025","article-title":"Molecular targets of fenofibrate in the cardiovascular-renal axis: a unifying perspective of its pleiotropic benefits","volume":"144","author":"Balakumar","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.biopha.2022.113076_bib35","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1038\/s41467-019-09375-8","article-title":"Oncogenic potential of truncated RXRalpha during colitis-associated colorectal tumorigenesis by promoting IL-6-STAT3 signaling","volume":"10","author":"Ye","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2022.113076_bib36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.molcel.2017.03.008","article-title":"Celastrol-Induced Nur77 interaction with TRAF2 alleviates inflammation by promoting mitochondrial ubiquitination and autophagy","volume":"66","author":"Hu","year":"2017","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.biopha.2022.113076_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/21623945.2021.1918863","article-title":"POU2AF1 promotes MSCs adipogenesis by inhibiting HDAC1 expression","volume":"10","author":"Wang","year":"2021","journal-title":"Adipocyte"},{"issue":"2","key":"10.1016\/j.biopha.2022.113076_bib38","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2017.10.031","article-title":"Preclinical models of non-alcoholic fatty liver disease","volume":"68","author":"Santhekadur","year":"2018","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113076_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0959-9673.2006.00465.x","article-title":"Mouse models in non-alcoholic fatty liver disease and steatohepatitis research","volume":"87","author":"Anstee","year":"2006","journal-title":"Int. J. Exp. Pathol."},{"issue":"12","key":"10.1016\/j.biopha.2022.113076_bib40","first-page":"2683","article-title":"Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL\/6 mice","volume":"6","author":"Itagaki","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"7","key":"10.1016\/j.biopha.2022.113076_bib41","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","article-title":"Liver PPARalpha is crucial for whole-body fatty acid homeostasis and is protective against NAFLD","volume":"65","author":"Montagner","year":"2016","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.biopha.2022.113076_bib42","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1478-3231.2006.01265.x","article-title":"Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver","volume":"26","author":"Harano","year":"2006","journal-title":"Liver Int."},{"issue":"2","key":"10.1016\/j.biopha.2022.113076_bib43","first-page":"1087","article-title":"2,3,5,4\u2032-tetrahydroxy-stilbene-2-O-beta-D-glucoside attenuates methionine and choline-deficient diet-induced non-alcoholic fatty liver disease","volume":"16","author":"Han","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"1","key":"10.1016\/j.biopha.2022.113076_bib44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/labinvest.2016.116","article-title":"CD68\/macrosialin: not just a histochemical marker","volume":"97","author":"Chistiakov","year":"2017","journal-title":"Lab. Investig."},{"issue":"2","key":"10.1016\/j.biopha.2022.113076_bib45","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-kappaB in the liver--linking injury, fibrosis and hepatocellular carcinoma","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2022.113076_bib46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/gut.2003.037010","article-title":"Adiponectin and its receptors in non-alcoholic steatohepatitis","volume":"54","author":"Kaser","year":"2005","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.biopha.2022.113076_bib47","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI200317797","article-title":"The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice","volume":"112","author":"Xu","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.biopha.2022.113076_bib48","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3389\/fphar.2018.01459","article-title":"Herbal extracts and natural products in alleviating non-alcoholic fatty liver disease via activating autophagy","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113076_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/diseases6030080","article-title":"Potential therapeutic benefits of herbs and supplements in patients with NAFLD","volume":"6","author":"Perumpail","year":"2018","journal-title":"Diseases"},{"key":"10.1016\/j.biopha.2022.113076_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.572729","article-title":"Chinese medicinal herbs targeting the gut-liver axis and adipose tissue-liver axis for non-alcoholic fatty liver disease treatments: the ancient wisdom and modern science","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2022.113076_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173976","article-title":"Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease","volume":"898","author":"Zhou","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2022.113076_bib52","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3389\/fphar.2020.00601","article-title":"Herbal medicine in the treatment of non-alcoholic fatty liver diseases-efficacy, action mechanism, and clinical application","volume":"11","author":"Xu","year":"2020","journal-title":"Front Pharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2022.113076_bib53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1034\/j.1600-0773.2002.910406.x","article-title":"Pien Tze Huang protects the liver against carbon tetrachloride-induced damage","volume":"91","author":"Lee","year":"2002","journal-title":"Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.biopha.2022.113076_bib54","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.3892\/mmr.2017.6936","article-title":"Pien Tze Huang Gan Bao attenuates carbon tetrachlorideinduced hepatocyte apoptosis in rats, associated with suppression of p53 activation and oxidative stress","volume":"16","author":"Zhao","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2022.113076_bib55","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.dld.2007.10.002","article-title":"A pilot trial of fenofibrate for the treatment of non-alcoholic fatty liver disease","volume":"40","author":"Fernandez-Miranda","year":"2008","journal-title":"Dig. Liver Dis."},{"issue":"2","key":"10.1016\/j.biopha.2022.113076_bib56","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"Schuppan","year":"2018","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.biopha.2022.113076_bib57","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.biopha.2022.113076_bib58","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jhep.2013.03.033","article-title":"Decoding cell death signals in liver inflammation","volume":"59","author":"Brenner","year":"2013","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.biopha.2022.113076_bib59","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1053\/j.gastro.2005.09.004","article-title":"NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis","volume":"129","author":"Dela Pena","year":"2005","journal-title":"Gastroenterology"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222004656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332222004656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:03:27Z","timestamp":1787598207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332222004656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":59,"alternative-id":["S0753332222004656"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113076","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The anti-inflammatory effect of Pien Tze Huang in non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2022.113076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"113076"}}